Owiredu W K B A, Quaye L, Amidu N, Addai-Mensah O
Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Afr Health Sci. 2013 Mar;13(1):101-11. doi: 10.4314/ahs.v13i1.14.
Antiretrovirals (ARVs) could lead to clinically significant nephrotoxicity and as such will require dose adjustments in the presence of renal insufficiency.
To explore renal function estimating equations as alternatives for glomerular filtration rate (GFR) measurement in a stable cohort of HIV-infected patients.
In estimating renal insufficiency in Ghanaian HIV-infected patients, GFR for 276 HAART-naïve patients and 166 patients on HAART was estimated with the Cockcroft-Gault, 4v-MDRD and CKD-EPI estimating equations.
Females outnumbered males by 3 to 1 in the HAART-naïve group and 4 to 1 in subjects on HAART. The prevalence of renal insufficiency calculated with the Cockcroft-Gault, 4v-MDRD and CKD-EPI equations was 8.7%, 9.1% and 8.7% in HAART-naïve patients; 14.5%, 12.6% and 12.6% in patients on HAART; 7.7%, 11.5% and 11.5% in HAART-naïve males; 10.8%, 8.1% and 8.1% in males on HAART; 9.1%, 8.0% and 7.5% in HAART-naïve females and 15.5%, 14.0% and 14.0% in females on HAART. The CKD-EPI equation yielded lower bias when compared to the Cockcroft-Gault and 4v-MDRD equations.
Renal insufficiency is not uncommon among HIV infected Ghanaian patients. A significant proportion (10 to 11%) will require ARV dose adjustment at the time of initiating therapy or sometime during on-going therapy.
抗逆转录病毒药物(ARV)可能导致具有临床意义的肾毒性,因此在肾功能不全的情况下需要调整剂量。
在一组稳定的HIV感染患者中,探索肾功能评估方程作为肾小球滤过率(GFR)测量的替代方法。
在评估加纳HIV感染患者的肾功能不全时,使用Cockcroft-Gault、4v-MDRD和CKD-EPI评估方程对276例未接受高效抗逆转录病毒治疗(HAART)的患者和166例接受HAART治疗的患者的GFR进行了评估。
在未接受HAART治疗的组中,女性与男性的比例为3比1;在接受HAART治疗的患者中,该比例为4比1。根据Cockcroft-Gault、4v-MDRD和CKD-EPI方程计算的肾功能不全患病率,在未接受HAART治疗的患者中分别为8.7%、9.1%和8.7%;在接受HAART治疗的患者中分别为14.5%、12.6%和12.6%;在未接受HAART治疗的男性中分别为7.7%、11.5%和11.5%;在接受HAART治疗的男性中分别为10.8%、8.1%和8.1%;在未接受HAART治疗的女性中分别为9.1%、8.0%和7.5%;在接受HAART治疗的女性中分别为15.5%、14.0%和14.0%。与Cockcroft-Gault和4v-MDRD方程相比,CKD-EPI方程产生的偏差更低。
肾功能不全在加纳HIV感染患者中并不罕见。相当一部分(10%至11%)患者在开始治疗时或持续治疗期间的某个时间需要调整ARV剂量。